Home / Inspections / 1117465

FDA Inspection 1117465 — Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals Inc — FEI 1000521995

The FDA completed an inspection of Regeneron Pharmaceuticals Inc on January 17, 2020 in Tarrytown, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 17, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Tarrytown, NY (United States)

Additional Details

Bioanalytical BA/BE

Facility

Other inspections at this facility

  • 1292476 (NAI Wed Dec 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1232732 (NAI Wed May 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1228712 (NAI Fri Jan 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1156180 (NAI Fri Oct 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1134447 (NAI Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources